2m 2m 2m 2m 2m 2m 2m
ELANC ANIML HLTH (ELAN)
NYSE
$22.95+$0.40 (+1.79%)
Price as of Oct 22, 2026 7:31 PM EDT- $11.3BMarket Cap
- 4.21%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ELANC ANIML HLTH (ELAN)
$22.95+$0.40 (+1.79%)
ELAN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $22.55 | ||
Change | -$0.15 (-0.66%) | ||
Open | $22.98 | ||
High | $22.98 | ||
Low | $22.23 | ||
Previous Close | $22.70 | ||
Volume | 4,860,730 | ||
30-Day Average Volume | 5,290,724 | ||
1-Week Change | 0.00% | ||
1-Month Change | 0.53% | ||
1-Year Change | 4.21% | ||
3-Year Change | 146.18% | ||
5-Year Change | -32.89% | ||
Fundamentals | |||
Shares Outstanding | 499.6M | ||
Total Assets | $13.6B | ||
Market Cap | $11.3B | ||
Enterprise Value | $14.7B | ||
Period: QTR TTM FY | |||
Revenue | $1.4B | ||
Net Income | $54.0M | ||
Free Cash Flow | $244.0M | ||
EBIT | $56.0M | ||
EBITDA | $227.0M | ||
Net Working Capital | $1.9B | ||
EPS | $0.11 | ||
Enterprise Value/EBITDA | 65 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 2 | ||
P/E | 205 | ||
PEG | N/A | ||
Price/Free Cash Flow | 46 | ||
Price/Operating Cash Flow | 41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue